Gender and age in lupus

Systemic Lupus Erythematosus, Fourth Edition

Volumn , Issue , 2004, Pages 203-221

  Lahita, Robert G ^a  

^a Liberty Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 20544450590     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012433901-9/50010-7     Document Type: Chapter

References (197)

1. P.J. Maddison, D.A. Isenberg, N.J. Goulding, J. Leddy and R.P. Skinner (1988) Anti La(SSB) identifies a distinctive subgroup of systemic lupus erythematosus. Br. J. Rheumatol. 27 27-31.
2. S.P. Ballou, M.A. Khan and I. Kushner (1982) Clinical features of SLE: Differences related to race and age of onset. Arthritis Rheum. 25 55.
3. E.V. Hess (1986) Drug related lupus: The same or different? R.G. Lahita (Eds) Systemic Lupus Erythematosus New York: Wiley 869-880.
4. M.B. Urowitz, M.B. Stevens and L.E. Shulman (1967) The influence of age on the clinical pattern of SLE. Arthritis Rheum. 10 319.
5. M. Maragou, F. Siotsiou, H. Sfondouris, Z. Nicolia, G. Vayopoulos and P. Dantis (1989) Late-onset systemic lupus erythematosus presenting as polymyalgia rheumatica. Clin. Rheumatol. 8 91-97.
6. R.E. Kellum and J.R. Haserick (1964) Systemic lupus erythematosus, a statistical evaluation of mortality based on a conservative series of 299 patients. Arch. Int. Med. 113 200.
7. C.C. Mok, C.S. Lau, K.W. Lee and R.W. Wong (1998) Hyperprolactinemia in males with systemic lupus erythematosus. J. Rheumatol. 25(12), 2357-2363.
8. S.B. Baker, J.R. Rovira, E.W. Campion and J.A. Mills (1979) Late onset SLE. Am. J. Med. 66 737.
9. H.A. Wilson, M.E. Hamilton and D.A. Spyker (1981) Age influences the clinical and serologic expression of SLE. Arthritis Rheum. 24 1230.
10. B.S.I. Foadd, R.P. Sheon and A.B. Kirsner (1972) Systemic lupus erythematosus in the elderly. Arch. Int. Med. 130 743.
11. D. Adu, D.G. Williams and D. Taube (1983) Late onset lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q. J. Med. 52 471.
12. A. Baer and T. Pincus (1983) Occult systemic lupus erythematosus in elderly men. JAMA 249 3350.
13. R.W. McMurray (1996) Prolactin and systemic lupus erythematosus. Ann. Med. Interne (Paris) 147(4), 253-258.
14. H.W. Liu, S.F. Lin, J.R. Chen, W.L. Chuang, J.H. Yen and J.H. Tsai (1988) Subset of systemic lupus erythematosus with late onset. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih 4 547-552.
15. S. Studenski, N.B. Allen, D.S. Caldwell, J.R. Rice and R.P. Polisson (1987) Survival in systemic lupus erythematosus: A multivariate analysis of demographic factors. Arthritis Rheum. 30 1326-1332.
16. M.M. Ward and S. Studenski (1990) Age associated clinical manifestations of systemic lupus erythematosus: A multivariate regression analysis. J. Rheum. 17 476-481.
17. R. Rashkov and K. Kunev (1990) The evolution of systemic lupus erythematosus. Vutr. Boles 29 91-96.
18. H. Hashimoto, H. Tsuda, T. Hirano, Y. Takasaki, T. Matsumoto and S. Hirose (1987) Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J. Rheumatol. 14 497-501.
19. M.C. Hochberg (1989) Mortality from systemic lupus erythematosus in England and Wales. 1974–1983. Br. J. Rheumatol. 26 437-441.
20. V. Harisdangkul, S. Nilganuwonge and L. Rockhold (1987) Cause of death in systemic lupus erythematosus: A pattern based on age at onset. South Med. J. 80 1249-1253.
21. H.A. Austin, L.R. Muenz, K.M. Joyce, T.A. Antonovych, M.E. Kullick, J.H. Klippel, et al. (1983) Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am. J. Med. 75 382-391.
22. M. Bielschowski and C.M. Goodall (1970) Origin of the inbred New Zealand mouse strains. Cancer Res. 30 834.
23. J.B. Howie and B.J. Helyer (1965) Autoimmune diseases in mice. Ann. N.Y. Acad. Sci. 124 167-177.
24. J.B. Howie and B.J. Helyer (1968) The immunology and pathology of NZB mice. Adv. Immunol. 9 215-266.
25. E.D. Murphy and J.B. Roths (1979) A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22 1188-1193.
26. S.E. Walker, R.H. Gray and M. Fulton (1978) Palmerston north mice, a new animal model of systemic lupus erythematosus. J. Lab. Clin. Med. 92 932.
27. S.E. Walker, A.B. Kier, E.C. Siegfied, B.G. Harris and J.S. Schultz (1986) Accelerated autoimmune disease and lymphoreticular neoplasms in F1 hybrid PN/NZB and NZB/PN mice. Clin. Immunol. Immunopathol. 39 81-92.
28. P.H. Lambert and F.J. Dixon (1968) Pathogenesis of the glomerulonephritis of NZB/W mice. J. Exp. Med. 127 507.
29. P.O. Teague, G.J. Irion and J.J. Myers (1968) Antinuclear antibodies in mice. I. Influence of age and possible genetic factors on spontaneous and induced responses. J. Immunol. 101 791.
30. G. Tonietti, M.B.A. Oldstone and F.J. Dixon (1970) The effect of induced chronic viraql infections on the immunological lesions of New Zealand white mice. J. Exp. Med. 132 89.
31. S.E. Walker, C.L. Besch-Williford and D.H. Keisler (1994) Accelerated deaths from systemic lupus erythematosus in NZB×NZW F1 mice treated with the testosterone-blocking drug flutamide. J. Lab. Clin. Med. 124 401-407.
32. G. Fernandez, E.J. Yunis and R.A. Good (1976) Age and genetic influences on immunity in NZB and autoimmune resistant mice. Clin. Immunol. Immunopathol. 6 318.
33. A. Gottlieb, R.G. Lahita, N. Chiorazzi and H.G. Kunkel (1979) Immune function in systemic lupus erythematosus. J. Clin. Invest. 63 885.
34. M.C. Gelfand and A.D. Steinberg (1973) Basis of impaired graft rejection of ageing NZB/W mice. Trans. Proc. 5 145.
35. T. Shirai, T. Yashiki and R.C. Mellors (1972) Age decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus dependent lymphocytes in NZB mice. Clin. Exp. Immunol. 12 455.
36. H.M. Motsopoulos, M. Boehm-Truitt and S.S. Kassan (1977) Demonstration of activation of B lymphocytes in New Zealand black mice at birth by an immunoradioactive assay for murine IgM. J. Immunol. 119 1639.
37. Y. Ohsugi and M.E. Gershwin (1979) Studies of congenitally immunologic mutant New Zealand mice. III. Growth of B lymphocyte clones in congenitally athymic (nude) and hereditary asplenic (Dh/+)NZB mice: A primary B cell defect. J. Immunol. 123 1260.
38. P.J. Staples, A.D. Steinberg and N. Talal (1980) Induction of immunological tolerance in older New Zealand mice repopoulated with young spleen, bone marrow, or thymus. J. Exp. Med. 131 1223.
39. J.I. Morton, D.A. Weyant, B.V. Seigel and B. Golding (1981) Androgen sensitivity and autoimmune disease. I. Influence of sex and testosterone on the humoral immune responses of autoimmune and nonautoimmune mouse strains to SRBC. Immunology 44 661.
40. P.K. Siiteri, L.A. Jones, J. Roubinian and N. Talal (1980) Sex steroids and the immune system. I. Sex difference in autoimmune disease in NZB/NZW hybrid mice. J. Steroid. Biochem. 12 425-432.
41. D.P. Stites and P. Siiteri (1983) Steroids as immunosuppressants in pregnancy. Immunol. Rev. 75 117-138.
42. H. Carlsten, R. Holmdahl, A. Tarkowski and L.A. Nilsson (1989) Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology 68 209-214.
43. J.R. Roubinian, N. Talal and J.S. Greenspan (1979) Delayed androgen treatment survival in murine lupus. J. Clin. Invest. 63 902-911.
44. J.R. Roubinian, N. Talal and J.S. Greenspan (1979) Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum. 22 1162-1169.
45. J.R. Roubinian, N. Talal, J.S. Greenspan, J.R. Goodman and P.K. Siiteri (1978) Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 147 1568.
46. Y. Weinstein and Z. Berkovich (1981) Testosterone effect on bone marrow, thymus and suppressor T cells in NZB×NZW F1 mice: Its relevance to autoimmunity. J. Immunol. 126 998-1002.
47. Y. Weinstein and Y. Isakov (1983) Effects of testosterone metabolites and of anabolic androgens on the bone marrow and thymus in castrated female mice. Immunopharmacology 5 229-237.
48. E.A. Novotny, E. Raveche and S. Sharrow (1983) Analysis of thymocyte subpopulations following treatment with sex hormones. Clin. Immunol. Immunopathol. 28 205-217.
49. E. Raveche, J.H. Tijo and A.D. Steinberg (1980) Genetic studies in NZB mice. IV. The effects of sex hormones on the spontaneous production of anti-T cell antibodies. Arthritis Rheum. 23 48.
50. E.S. Raveche, R.A. Vigersky, M.K. Rice and A.D. Steinberg (1980) Murine thymic androgen receptors. J. Immunopharmacol. 2 425.
51. M.A. Detelfsen, B.C. Smith and H.W. Dickerman (1979) A high affinity, low capacity receptor for estradiol in normal and anemic mouse spleen cytosols. Biochem. Biophys. Res. Commun. 76 1151.
52. E.J. Golsteyn and M.J. Fritzler (1987) The role of the thymus-hypothalamus-pituitary-gonadal axis in normal immune processes and autoimmunity. J. Rheumatol. 14 982-990.
53. A.N. Theofilopoulos and F. Dixon (1986) Experimental murine systemic lupus erythematosus. R.G. Lahita (Eds) Systemic Lupus Erythematosus New York: Wiley 121-202.
54. L. Hang, A.N. Theofilopoulos and F.J. Dixon (1982) A spontaneous rheumatoid arthritis-like disease in MRL/1 mice. J. Exp. Med. 155 1690.
55. A.N. Theofilopoulos, D.R. Shawler and R.A. Eisenberg (1980) Splenic immunoglobulin secreting cells and their regulation in autoimmune mice. J. Exp. Med. 151 445.
56. B.S. Andrews, R.A. Eisenberg and A.N. Theofilopoulos (1978) Spontaneous murine lupus-like syndromes: Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148 1198.
57. A.D. Steinberg, K.A. Melez, E.S. Raveche, J.P. Reeves, W.A. Boegel, P.A. Smathers, et al. (1979) Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum. 22 1170.
58. A.D. Steinberg, J.B. Roths and E.D. Murphy (1980) Effects of thymectomy and androgen administration upon the autoimmune disease of MRL/Mo-lpr/lpr mice. J. Immunol. 125 871.
59. R.A. Eisenberg and F.J. Dixon (1980) Effect of castration on male determined acceleration of autoimmune disease in BXSB mice. J. Immunol. 125 1939-1963.
60. R.A. Eisenberg, S. Izui and P.J. McConahey (1980) Male determined accelerated autoimmune disease in BXSB mice: Transfer by bone marrow and spleen cells. J. Immunol. 125 1032.
61. E. Mazes and S. Fuchs (1974) Linkage between immune response potential to DNA and X chromosome. Nature 249 167-168.
62. C.A. Laskin, J.D. Taurog, P.A. Smathers and A.D. Steinberg (1981) Studies of defective tolerance on murine lupus. J. Immunol. 127 1743.
63. R.C. Kuppers, T. Suiter, E. Gleichman and N.R. Rose (1988) The induction of organ-specific antibodies during the graft-vs-host reaction. Eur. J. Immunol. 18 161-166.
64. A.S. Fuks and Y. Weinstein (1979) 20 alpha-hydroxysteroid dehydrogenase (20 alpha SDH) activity in New Zealand mice: T lymphocytes and bone marrow cells. J. Immunol. 213 1266.
65. L.J. Jara, C. Lavalle, A. Fraga, C. Gomez-Sanchez, L.H. Silveira, P. Maritnez-Osuna, et al. (1991) Prolactin, immunoregulation, and autoimmune diseases. Semin Arthritis Rheum. 20 273-284.
66. S.E. Walker (1993) Prolactin: An immune-stimulating peptide that regulates other immune-modulating hormones. Lupus 2 67-69.
67. S.E. Walker, S.H. Allen, R.W. Hoffman and R.W. McMurray (1995) Prolactin: A stimulator of disease activity in systemic lupus erythematosus. Lupus 4 3-9.
68. R.W. McMurray (2001) Prolactin in murine systemic lupus erythematosus. Lupus 10(10), 742-747.
69. K.B. Elbourne, D. Keisler and R.W. McMurray (1998) Differential effects of estrogen and prolactin on auto-immune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus. Lupus 7(6), 420-427.
70. R.G. Lahita (1992) Sex steroids and SLE: Metabolism of androgens to estrogens. Lupus 1 125-127.
71. T.A. Chapel and R.E. Burns (1971) Oral contraceptives and exacerbations of SLE. Am. J. Obst. Gynec. 110 366.
72. M. Petri and C. Robinson (1997) Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum. 40(5), 797-803.
73. E. Rose and D.M. Pillsbury (1944) Lupus erythematosus (erythematodes) and ovarian function: Observations on a possible relationship with a report of six cases. Ann. Int. Med. 21 1022.
74. G. Bjune (1979) In vitro lymphocyte responses to PHA show co-variation with the menstrual cycle. Immunol. Abstracts 51
75. S. Manzi, E.N. Meilahn, J.E. Rairie, C.G. Conte, T.A. Medsger, L. Jansen-McWilliams, et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study. Am. J. Epidemiol. 145(5), 408-415.
76. R.G. Lahita and H.L. Bradlow (1987) Klinefelter's syndrome: Hormone metabolism in hypogonadal males with systemic lupus erythematosus. J. Rheumatol. 14(Suppl. 13), 154-157.
77. R.G. Lahita (1992) The importance of estrogens in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 63 17-18.
78. R.G. Lahita (1986) The influence of sex hormones on the disease systemic lupus erythematosus. Springer Semin. Immunopathol 9 305-314.
79. R. Bucala, R.G. Lahita, J. Fishman and A. Cerami (1987) Anti-estrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematosus. Clini. Exp. Immunol. 67 167-175. [Abstract]
80. J. Fishman and C. Martucci (1980) Biological properties of 16-alpha hydroxyestrone: Implicationso in estrogen physiology and pathophysiology. J. Clin. Endo. Metab. 51 611-615.
81. S. Ikegawa, R.G. Lahita and J. Fishman (1983) Concentration of 16 alpha hydroxyestrone in human plasma as measured by a specific RIA. J. Steroid Biochem. 18 329-332.
82. R. Bucala, J. Fishman and A. Cerami (1982) Formation of co-valent adducts between cortisol and 16-alpha-hydroxyestrone and protein, possible role in pathogenesis of cortisol topxicity and SLE. Proc. Nat. Acad. Sci. 79 3320.
83. R. Bucala, J. Fishman and A. Cerami (1984) The reaction of 16-a hydroxyestrone with erythrocytes in vitro and in vivo. Eur. J. Biochem. 140 593-598.
84. R.G. Lahita, H.L. Bradlow, J. Fishman and H.G. Kunkel (1982) Estrogen metabolism in systemic lupus erythematosus: Patients and family members. Arthritis Rheum. 25 843-846.
85. R.D. Inman (1978) Immunologic sex differences and the female preponderance in systemic lupus erythematosus. Arthritis Rheum. 21 849-852.
86. R.D. Inman, L. Jovanovic and J.A. Markenson (1982) Systemic lupus erythematosus in men: Genetic and endocrine features. Arch. Int. Med. 142 1813-1815.
87. R.G. Lahita, H.L. Bradlow, H.G. Kunkel and J. Fishman (1983) Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum. 26 1517-1521.
88. R.G. Lahita, H.L. Bradlow, E. Ginzler, S. Pang and M. New (1987) Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum. 30 241-248.
89. P. Jungers, K. Nahoul and C. Pelissier (1982) Low plasma androgens in women with active or quiescent SLE. Arthritis Rheum. 25 454-457.
90. P. Jungers, C. Pelissier, J.F. Bach and K. Nahoul (1980) Les androgenes plasmatiques chez les femmes atteintes de lupus erythemateux dissemine (LED). Pathol. Biol. 28 391-392.
91. A. El-Garf, S. Salah, M. Shaarawy, S. Zaki and S. Anwer (1996) Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations. J. Rheumatol. 23(2), 374-377.
92. M.A. Gutierrez, J.F. Molina, L.J. Jara, C. Garcia, S. Gutierrez-Urena, M.L. Cuellar, et al. (1996) Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int. Arch. Allergy Immunol. 109(3), 229-235.
93. A.A. Lash (1993) Why so many women? 1. Systemic lupus erythematosus. Medsurg. Nurs. 2(4), 259-264.
94. M. Folomeev, M. Dougados, J. Beaune, J.C. Kouyoumdjian, K. Nahoul, B. Amor, et al. (1992) Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1(3), 191-195.
95. L. Jara-Quezada, A. Graef and C. Lavalle (1991) Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J. Rheum. 18 349-353.
96. C. Lavalle, E. Loyo, R. Paniagua, J.A. Bermudez, J. Herrera, A. Graef, et al. (1987) Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J. Rheumatol. 14 268-272.
97. C.C. Mok and C.S. Lau (1994) Lack of association between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J. Rheumatol. 23(12), 2185-2186.
98. B. Ostendorf, R. Fischer, R. Santen, B. Schmitz-Linneweber, C. Specker and M. Schneider (1996) Hyperprolactinemia in systemic lupus erythematosus? Scand. J. Rheumatol. 25(2), 97-102.
99. D. Buskila, M. Lorber, L. Neumann, D. Flusser and Y. Shoenfeld (1996) No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J. Rheumatol. 23(4), 629-632.
100. C.C. Mok, C.S. Lau and S.C. Tam (1997) Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients. Br. J. Rheumatol. 36(9), 986-989.
101. D. Kozakova, J. Rovensky, L. Cebecauer, V. Bosak, E. Jahnova and M. Vigas (2000) Prolactin levels and autoantibodies in female patients with systemic lupus erythematosus. Z. Rheumatol. 59(Suppl. 2), II/80-II/84.
102. A. Leanos-Miranda, K.A. Chavez-Rueda and F. Blanco-Favela (2001) Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Arthritis Rheum. 44(4), 866-875.
103. A. Leanos-Miranda, D. Pascoe-Lira, K.A. Chavez-Rueda and F. Blanco-Favela (2001) Antiprolactin autoantibodies in systemic lupus erythematosus: Frequency and correlation with prolactinemia and disease activity. J. Rheumatol. 28(7), 1546-1553.
104. M. Pacilio, S. Migliaresi, R. Meli, L. Ambrosone, B. Bigliardo and R. Di Carlo (2001) Elevated bioactive prolactin levels in systemic lupus erythematosus: Association with disease activity. J. Rheumatol. 28(10), 2216-2221.
105. J.M. Miranda, R.E. Prieto, R. Paniagua, G. Garcia, D. Amato, L. Barile, et al. (1998) Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus 7(6), 387-391.
106. F. Blanco-Favela, G. Quintal-Alvarez and A. Leanos-Miranda (1999) Association between prolactin and disease activity in systemic lupus erythematosus: Influence of statistical power. J. Rheumatol. 26(1), 55-59.
107. L.J. Jara, O. Vera-Lastra, J.M. Miranda, M. Alcala and J. Alvarez-Nemegyei (2001) Prolactin in human systemic lupus erythematosus. Lupus 10(10), 748-756.
108. A.M. Jacobi, W. Rohde, H.D. Volk, T. Dorner, G.R. Burmester and F. Hiepe (2001) Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann. Rheum. Dis. 60(3), 242-247.
109. A.M. Jacobi, W. Rohde, M. Ventz, G. Riemekasten, G.R. Burmester and F. Hiepe (2001) Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 10(8), 554-561.
110. A. Stevens, D.W. Ray, J. Worthington and J.R. Davis (2001) Polymorphisms of the human prolactin gene: Implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus 10(10), 676-683.
111. G.S. Cooper, M.A. Dooley, E.L. Treadwell, E.W. St. Clair and G.S. Gilkeson (2002) Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population-based, case-control study. Arthritis Rheum. 46(7), 1830-1839.
112. N. Stahl and J. Decker (1978) Androgenic status of males with SLE. Arthritis Rheum. 21 665-668.
113. R.G. Lahita (1993) Sex hormones as immunomodulators of disease. Ann. N. Y. Acad. Sci. 685 278-287.
114. R.G. Lahita (1985) Sex steroids and the rheumatic diseases. Arthritis Rheum. 28 121-126.
115. R.G. Lahita, H.L. Bradlow, H.G. Kunkel and J. Fishman (1981) Increased 16 alpha hydroxylation of estradiol in systemic lupus erythematosus. J. Clin. Endo. Metab. 53 174-178.
116. R.G. Lahita, N. Chiorazzi and A. Gibofsky (1983) Familial systemic lupus erythematosus in males. Arthritis Rheum. 26 39.
117. C.M. Stein, J.M. Olson, C. Gray-McGuire, G.R. Bruner, J.B. Harley and K.L. Moser (2002) Increased prevalence of renal disease in systemic lupus erythematosus families with affected male relatives. Arthritis Rheum. 46(2), 428-435.
118. S. Ansar Ahmed, W.J. Penhale and N. Talal (1985) Sex hormones, immune responses, and autoimmune diseases: Mechanisms of sex hormone action. Am. J. Pathol. 121 531-551.
119. M. Blank, S. Mendlovic, H. Fricke, E. Mozes, N. Talal and Y. Shoenfeld (1990) Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice. J. Rheumatol. 17 311-317.
120. G.R. Hughes (1984) Current understanding of systemic lupus erythematosus. Inflammation 8(Suppl.), S75-S79.
121. Z.M. Sthoeger, D. Geltner, A. Rider and Z. Bentwich (1987) Systemic lupus erythematosus in 49 Israeli males: A retrospective study. Clin. Exp. Rheum. 5 233-240.
122. H. Anisman, M.G. Baines, I. Berczi, C.N. Bernstein, M.G. Blennerhassett, R.M. Gorczynski, et al. (1996) Neuroimmune mechanisms in health and disease. 2. Disease. Can. Med. Assoc. J. 155(8), 1075-1082.
123. F. Camilleri and C. Mallia (1999) Male SLE patients in Malta. Adv. Exp. Med. Biol. 455 173-179.
124. D.M. Chang, C.C. Chang, S.Y. Kuo, S.J. Chu and M.L. Chang (1999) Hormonal profiles and immunological studies of male lupus in Taiwan. Clin. Rheumatol. 18(2), 158-162.
125. C.C. Mok and C.S. Lau (2000) Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus 9(4), 252-257.
126. Z.S. Alekberova and M.I. Folomeev (1985) Sexual dimorphism in rheumatic diseases. Revmatologiia (Mosk) 58-61.
127. M. Folomeev, Z. Alekberova and J. Polyntsev (1990) The role of estrogen androgen imbalance in rheumatic diseases. Terapeuticheskii Arkhiv 62(5), 17-21.
128. Z. Alekberova, G. Kotelnikova and M. Folomeev (1989) Aortic defects in systemic lupus erythematosus. Terapeuticheskii Arkhiv 61(5), 35-38.
129. K. Bosmansky and S. Kopecky (1979) Progressive polyarthritis and Klinefelter's syndrome. Fysiatr Revmatol Vestn 57 160-163.
130. A. Fam, M. Izsak and C. Saiphoo (1980) SLE and Klinefelter's syndrome. Arthritis Rheum. 23 124.
131. M.A.H. French and P. Hughes (1983) Systemic lupus erythematosus and Klinefelter's syndrome. Ann. Rheum. Dis. 42 471-473.
132. F. Harris (1980) Congenital hypothyroidism and Klinefelter's syndrome. J. Med. Genet. 17 326-327.
133. S. Kobayashi, T. Shimamoto, O. Taniguchi, H. Hashimoto and S. Hirose (1989) A case report of Klinefelter's syndrome associated with progressive systemic sclerosis. Nippon Naika Gakkai Zasshi 78 854-855.
134. S. Kobayashi, T. Shimamoto, O. Taniguchi, H. Hashimoto and S. Hirose (1991) Klinefelter's syndrome associated with progressive systemic sclerosis: Report of a case and review of the literature. Clin. Rheumatol. 10 84-86.
135. M.B. Vallotton and A.P. Forbes (1967) Autoimmunity in gonadal dysgenesis and Klinefelter's syndrome. Lancet 1 648-651. [Abstract]
136. L.C. Harrison, B. Dean, I. Peluso, S. Clark and G. Ward (1985) Insulin resistance, acanthosis nigricans, and polycystic ovaries associated with a circulating inhibitor of postbinding insulin action. J. Clin. Endo. Metab. 60 1047-1052.
137. W.P. Dmowski, H.M. Geber and R.G. Rawlins (1989) Immunological aspects of endometriosis. Obstetr. Gynecol. Clin. North Am. 93-103.
138. W.P. Dmowski, R.W. Steele and G.F. Baker (1981) Deficicent cellular immunity in endometriosis. Am. J. Obstets. Gynecol. 141 377.
139. M.A. Gutierez, J.M. Anaya, G.E. Cabrera, O. Vindrola and L.R. Espinoza (1994) Prolactin, a link between the neuroendocrine and immune systems: Role in the pathogenesis of rheumatic diseases. Rev. Rhum. Ed. Fr. 61(4), 278-285.
140. J. Sanchez-Guerrero, E. Karlson, M.H. Liang, D.J. Hunter, F.E. Speizer and G.A. Colditz (1997) Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum. 40(5), 804-808.
141. M.H. Liang and E.W. Karlson (1996) Female hormone therapy and the risk of developing or exacerbating systemic lupus erythematosus or rheumatoid arthritis. Proc. Assoc. Am. Phys. 108(1), 25-28.
142. J. Buyon, H.M. Korchack and L.E. Rutherford (1984) Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum. 27 623-630.
143. P. Bodel, G.M. Dillard, S.S. Kaplan and S.E. Malawista (1972) Antiinflammatory effects of estradiol on human blood leukocytes. J. Lab. Clin. Med. 80 373-384.
144. W.M. Mikkelson, N.J. Dodge and H. Vlakenberg (1965) The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia. Am. J. Med. 39 242.
145. M.D. Lockshin (2001) Invited review: Sex ratio and rheumatic disease. J. Appl. Physiol. 91(5), 2366-2373.
146. A. Linos, W.M. O'Fallon, J.W. Worthington and L.T. Kurland (1983) Case control study of rheumatoid arthritis and prior use of oral contraceptives. Lancet 1 1299.
147. A. Linos, J.W. Worthing, W.M. O'Fallon and L.T. Kurland (1989) The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of its incidence, prevalence, and mortality. Am. J. Epidem. 111 87-98.
148. M. Oka and U. Vainio (1966) Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta. Rheum. Scand. 12 47.
149. C.C. Mok, C.S. Lau, C.T. Ho and R.W. Wong (1999) Do flares of systemic lupus erythematosus decline after menopause? Scand. J. Rheumatol. 28(6), 357-362.
150. J. Sanchez-Guerrero, A. Villegas, A. Mendoza-Fuentes, J. Romero-Diaz, G. Moreno-Coutino and M.C. Cravioto (2001) Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am. J. Med. 111(6), 464-468.
151. V. Agnello, K. Pariser and J. Gell (1983) Preliminary observation on Danazol therapy of systemic lupus: Effects on DNA antibodies, thrombocytopenia and complement. J. Rheumatol. 10 682-687.
152. V.H. Donaldson and E.V. Hess (1980) Effect of danazol on lupus erythematosus like disease in hereditary angioneurotic edema. Lancet 2 1143.
153. M. Dougados, C. Job-deselandre, B. Amor and J. Menkes (1987) Danazol therapy in systemic lupus erythematosus. Clin. Trials. J. 24 191-200.
154. M. Fretwell and L.O. Altman (1982) Exacerbation of a lupus erythematosus-like syndrome during treatment of non-C 1 esterase inhibitor dependent angioedema with danazol. J. Allergy. Clin. Immunol. 69 306-310.
155. Y.S. Ahn, R. Mylvaganam, R.O. Garcia, C.I. Kim, D. Palow and W.J. Harrington (1987) Low-dose danazol therapy in idiopathic thrombocytopenic purpura. Ann. Intern. Med. 107 177-181.
156. R. Mylvaganam, Y.S. Ahn, R.O. Garcia, C.I. Kim and W.J. Harrington (1989) Very low dose danazol in idiopathic thrombocytopenic purpura and its role as an immune modulator. Am. J. Med. Sci. 298 215-220.
157. R.G. Lahita, C.Y. Cheng, C. Monder and C.W. Bardin (1992) Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: Worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women. J. Rheumatol. 19 547-555.
158. F. Liote, V. Dehaine, C. Pelissier, F. Kuttenn and P. Jungers (1991) Hormonal modulation with cyproterone acetate in systemic lupus erythematosus: A long term follow-up study. Arthritis Rheum. [Abstract]
159. A. El-Roeiy, W.P. Dmowski and N. Gleicher (1988) Effect of danazol and GnRH agonists (GnRH-a) on the immune system in endometriosis. Soc. Gynecol. Invest. 283 [Abstract]
160. K. Sudo, K. Shiota, T. Masaki and T. Fujita (1991) Effects of TAP-144-SR, a sustained-release formulation of a potent GnRH agonist, on experimental endometriosis in the rat. Endocrinol. Jpn. 38 39-45.
161. O. Khorram, L. Vu and S.C.C. Yen (1997) Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J. Gerontol. 52A(1), 1-7.
162. N.F.L. Spencer, M.E. Poynter, J.D. Hennebold, H.H. Mu and R.A. Daynes (1996) Does DHEAS restore immune competence in aged animals through its capacity to function as a natural modulator of peroxisome activities? F.L. Bellino, R.D. Daynes, P.J. Hornsby, D.H. Lavren, J.E. Nestler (Eds) Dehydroepiandrosterone (DHEA) and Aging New York: New York Academy of Sciences 200-216.
163. B.A. Araneo and R.A. Daynes (1995) Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury. Endo 136(2), 393-401.
164. R.A. Daynes and B.A. Araneo (1992) Programming of lymphocyte responses to activation: Extrinsic factors, provided microenvironementally, confer fllexibility and compartmentalization to T cell function. Chem. Immunol. 54 1-20.
165. R.A. Daynes, D.J. Dudley and B.A. Araneo (1990) Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. J. Immunol. 20 793-802.
166. K. Nandy, L. Harbous, D. Bennet and M. Bennet (1983) Correlation between learning disorder and elevated brain reactive antibodies in aged C57B1/6 and young NZB mice. Life Sci. 33 1499.
167. N. Geschwind and P. Behan (1972) Left handedness: Association with immune disease, migraine and developmental learning disorders. Proc. Nat. Acad. Sci. USA 74 5097.
168. R.G. Lahita (1988) Systemic lupus erythematosus: Learning disability in the male offspring of female patients and relationship to laterality. Psychoneuroendocrinology 13 385-396.
169. G.F. Sherman, A.M. Galaburda and N. Geschwind (1983) Ectopic neurons in the brain of the autoimmune mouse: A neuropathophysiologic model of dyslexia? Neuropathol. Proc. 275 6.
170. L.C. Wood and D.S. Cooper (1989) Autoimmune thyroid disease, left-handedness and developmental dyslexia. Unpublished work
171. S.A. Ahmed, M. Dauphinee and N. Talal (1985) Effects of short term administration of sex hormones on normal and autoimmune mice. J. Immunol. 134 204-210.
172. R.J. Ablin, G.R. Bruns, P. Guinan and I.M. Bush (1974) Antiandrogenic suppression of lymphocytic blastogenesis: In vitro and in vivo observations. Experientia 30 1351.
173. G. Dorner, R. Eckert and G. Hinz (1980) Androgen dependent sexual dimorphism of the immune system. Endocrinologie 76 112.
174. Y. Hirota, T. Suzuki and Y. Bito (1980) The B-cell development independent of bursa of Fabricius but dependent upon the thymus in chickens treated with testosterone propionate. Immunology 39 37-46.
175. Y. Hirota, T. Suzuki and Y. Bito (1980) The development of unusual B-cell functions in the testosterone-propionate treated chicken. Immunology 39 29.
176. Y. Hirota, T. Suzuki, Y. Chazono and Y. Bito (1976) Humoral immune responses characteristics of testosterone propionate treated chickens. Immunology 30 341.
177. C. Grossman (1989) Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. J. Steroid Biochem. 34 241-251.
178. C.J. Grossman (1984) Regulation of the immune system by sex steroids. Endocr. Rev. 5 435-455.
179. C.J. Grossman (1988) The importance of hormones in the regulation of the immune system. Immunol. Allergy Pract. 10 104-106.
180. D.B. Lubahn, D.R. Joseph, M. Sar, J. Tan, H.N. Higgs, R.E. Larson, et al. (1988) The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol. Endocrinol. 2 1265-1275.
181. L. Klareskog, U. Forsum and P.A. Peterson (1980) Hormonal regulation of the expression of Ia antigens on mammary gland epithelia. Eur. J. Immunol. 10 958-963.
182. G. Terres, S.L. Morrison and G.L. Habicht (1968) A quantitative difference in the immune response between male and female mice. Proc. Exp. Biol. Med. 27 664.
183. J.S. Thompson, M.K. Crawford, R. Reilly and C. Stevenson (1957) Estrogenic hormones in immune responses in normal and X irradiated mice. J. Immunol. 98 331.
184. S.R. Waltman, R.M. Brude and J. Benios (1971) Prevention of corneal rejection by estrogens. Transplantation 11 194.
185. J.Y. Brodie, I.C. Hunter, W.H. Stimson and B. Green (1980) Specific estradiol binding in cytosols from the thymus glands of normal and hormone-treated male rats. Thymus 1 337.
186. F.A. Wyle and J.R. Kent (1977) Immunosuppression by sex steroid hormones. I. The effect upon PHA- and PPD-stimulated lymphocytes. Clin. Exp. Immunol. 27 407-415.
187. P.S. Satoh, W.E. Fleming, K.A. Johnstone and J.M. Ozmun (2002) Active E rosette formation in women taking oral contraceptives. N. Eng. J. Med. 296 54.
188. N.J. Olsen, M.B. Watson, G.S. Henderson and W.J. Kovacs (1991) Androgen deprivation induces phenotypic and functional changes in the thymus of adult male mice. Endo 129 2471-2476.
189. S. Sasson and M. Mayer (1981) Effect of androgenic steroids on rat thymus and thymocytes in suspension. J. Steroid Biochem. 14 509-518.
190. R.J. Graff, M.A. Lappe and G.D. Snell (1969) The influence of the gonads and the adrenal glands on the immune response to skin grafts. Transplantation 7 105.
191. D. Buskila, M. Berezin, H. Gur, H.C. Lin, I. Alosachie, J.W. Terryberry, et al. (1995) Autoantibody profile in the sera of women with hyperprolactinemia. J. Autoimmun. 8(3), 415-424.
192. T. Paavonen, H. Aronen, S. Pyrhonen, A. Hajba and L.C. Andersson (1991) The effects of anti-estrogen therapy on lymphocyte functions in breast cancer patients. APMIS 99 163-170.
193. Z.M. Sthoeger, N. Chiorazzi and R.G. Lahita (1988) Regulation of the immune response by sex hormones. I. In vivo effects of estradiol and testosterone on pokeweed mitogen-induced B-cell differentiation. J. Immunol. 141 91.
194. J.H.M. Cohen, L. Danel, G. Cordier, S. Saez and J. Revillard (1983) Sex steroid receptors in peripheral T cells: Absence of androgen receptors and restriction of estrogen receptors to OKT8 positive cells. J. Immunol. 131 2767-2771. [Abstract]
195. L. Danel, G. Sovweine, J.C. Monier and S. Saez (1983) Specific estrogen binding sites in human lymphoid cells and thymic cells. J. Steroid Biochem. 18 559.
196. T. Jo, N. Terada, F. Saji and O. Tanizawa (1993) Inhibitory effects of estrogen, progesterone, androgen and glucocorticoid on death of neonatal mouse uterine epithelial cells induced to proliferate by estro. J. Steroid Biochem. Mol. Biol. 46(1), 25-32.
197. T. Mori, H. Kobayashi and H. Nishimoto (1977) Inhibitory effect of progesterone and 20-hydroxy-pregn-4-en-3-one on the phytohemagglutinin-induced transformation of human lymphocytes. Am. J. Obstet Gynecol. 127 151.